Literature DB >> 11018658

Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis.

S D Allison1, M C Molina, T J Anchordoquy.   

Abstract

The instability of nonviral vectors in aqueous suspensions has stimulated an interest in developing lyophilized formulations for use in gene therapy. Previous work has demonstrated a strong correlation between the maintenance of particle size and retention of transfection rates. Our earlier work has shown that aggregation of nonviral vectors typically occurs during the freezing step of the lyophilization process, and that high concentrations of sugars are capable of maintaining particle size. This study extends these observations, and demonstrates that glass formation is not the mechanism by which sugars protect lipid/DNA complexes during freezing. We also show that polymers (e.g., hydroxyethyl starch) are not capable of preventing aggregation despite their ability to form glasses at relatively high subzero temperatures. Instead, our data suggest that it is the separation of individual particles within the unfrozen fraction that prevents aggregation during freezing, i.e., the particle isolation hypothesis. Furthermore, we suggest that the relatively low surface tension of mono- and disaccharides, as compared to starch, allows phase-separated particles to remain dispersed within the unfrozen excipient solution, which preserves particle size and transfection rates during freezing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018658     DOI: 10.1016/s0005-2736(00)00251-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Metal contaminants promote degradation of lipid/DNA complexes during lyophilization.

Authors:  Marion d C Molina; Thomas J Anchordoquy
Journal:  Biochim Biophys Acta       Date:  2006-12-08

2.  Effects of moisture content on the storage stability of dried lipoplex formulations.

Authors:  Jinxiang Yu; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

3.  Synergistic effects of surfactants and sugars on lipoplex stability during freeze-drying and rehydration.

Authors:  Jinxiang Yu; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

4.  Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying.

Authors:  Praveen V Date; Abdul Samad; Padma V Devarajan
Journal:  AAPS PharmSciTech       Date:  2010-02-25       Impact factor: 3.246

5.  The Potential of Exosomes From Cow Milk for Oral Delivery.

Authors:  Jamie L Betker; Brittany M Angle; Michael W Graner; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2018-11-20       Impact factor: 3.534

6.  Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells.

Authors:  Long Xu; Thomas J Anchordoquy
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

7.  Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds.

Authors:  Anita Saraf; L Scott Baggett; Robert M Raphael; F Kurtis Kasper; Antonios G Mikos
Journal:  J Control Release       Date:  2009-12-16       Impact factor: 9.776

8.  Naked plasmid DNA formulation: effect of different disaccharides on stability after lyophilisation.

Authors:  Susanne G L Quaak; John B A G Haanen; Jos H Beijnen; Bastiaan Nuijen
Journal:  AAPS PharmSciTech       Date:  2010-03-04       Impact factor: 3.246

9.  Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Control Release       Date:  2009-10-17       Impact factor: 9.776

Review 10.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.